JP2011516037A5 - - Google Patents

Download PDF

Info

Publication number
JP2011516037A5
JP2011516037A5 JP2010550627A JP2010550627A JP2011516037A5 JP 2011516037 A5 JP2011516037 A5 JP 2011516037A5 JP 2010550627 A JP2010550627 A JP 2010550627A JP 2010550627 A JP2010550627 A JP 2010550627A JP 2011516037 A5 JP2011516037 A5 JP 2011516037A5
Authority
JP
Japan
Prior art keywords
ins
seq
binding agent
fragment
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010550627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011516037A (ja
JP5818440B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NZ2009/000031 external-priority patent/WO2009113879A1/en
Publication of JP2011516037A publication Critical patent/JP2011516037A/ja
Publication of JP2011516037A5 publication Critical patent/JP2011516037A5/ja
Application granted granted Critical
Publication of JP5818440B2 publication Critical patent/JP5818440B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010550627A 2008-03-12 2009-03-12 バイオマーカー Expired - Fee Related JP5818440B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3577008P 2008-03-12 2008-03-12
US61/035,770 2008-03-12
PCT/NZ2009/000031 WO2009113879A1 (en) 2008-03-12 2009-03-12 Biomarkers

Publications (3)

Publication Number Publication Date
JP2011516037A JP2011516037A (ja) 2011-05-26
JP2011516037A5 true JP2011516037A5 (enExample) 2012-06-07
JP5818440B2 JP5818440B2 (ja) 2015-11-18

Family

ID=41065427

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010550627A Expired - Fee Related JP5818440B2 (ja) 2008-03-12 2009-03-12 バイオマーカー

Country Status (9)

Country Link
US (2) US9630985B2 (enExample)
EP (1) EP2265641B1 (enExample)
JP (1) JP5818440B2 (enExample)
CN (2) CN102037014A (enExample)
AU (1) AU2009224113B2 (enExample)
CA (1) CA2715914C (enExample)
DK (1) DK2265641T3 (enExample)
ES (1) ES2666725T3 (enExample)
WO (1) WO2009113879A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5818440B2 (ja) 2008-03-12 2015-11-18 オタゴ イノベーション リミテッド バイオマーカー
US20140147874A1 (en) * 2011-03-04 2014-05-29 The Johns Hopkins University Biomarkers of cardiac ischemia
EP2592422A1 (en) * 2011-11-08 2013-05-15 Zora Biosciences OY Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
CN111566238A (zh) 2017-09-14 2020-08-21 利希维亚公司 分离铜族金属的方法和组合物
JP7523358B2 (ja) 2018-06-13 2024-07-26 アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニ ムスカリン受容体m3に対して阻害活性を有するペプチド
CN116199793B (zh) * 2023-03-13 2025-05-02 广州源博医药科技有限公司 一种长效重组犬胰岛素融合蛋白的制备方法及其应用

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5310687A (en) * 1984-10-31 1994-05-10 Igen, Inc. Luminescent metal chelate labels and means for detection
GB8800077D0 (en) 1988-01-05 1988-02-10 Ciba Geigy Ag Novel chimeric antibodies
US5843708A (en) 1988-01-05 1998-12-01 Ciba-Geigy Corporation Chimeric antibodies
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5028535A (en) * 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
JPH05506218A (ja) * 1990-05-07 1993-09-16 イムノメデイツクス・インコーポレイテツド 一価の抗体フラグメントの改良された放射性標識方法
JPH05504841A (ja) * 1990-09-14 1993-07-22 バイオサイト・ダイアグノスティックス・インコーポレイテッド リガンドレセプター及びリガンドのコンプレックスに対する抗体及びリガンド―レセプターアッセーでのそれらの用途
DE69129154T2 (de) * 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
US5221685A (en) * 1991-02-01 1993-06-22 Ube Industries, Ltd. Thiazoline derivative, process for preparing the same and chemical for controlling noxious organisms containing the same
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
WO1992018868A1 (en) 1991-04-10 1992-10-29 Biosite Diagnostics Incorporated Crosstalk inhibitors and their uses
ATE195808T1 (de) * 1991-04-12 2000-09-15 Biosite Diagnostics Inc Neue konjugate und testverfahren für die gleichzeitige bestimmung von multiplen liganden
US6143576A (en) * 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US5494829A (en) * 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5605798A (en) * 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
EP1347493A3 (en) * 1993-05-28 2005-11-23 Baylor College Of Medicine Method and apparatus for desorption and ionization of analytes
US5824799A (en) * 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
ATE224053T1 (de) 1993-11-12 2002-09-15 Inverness Medical Switzerland Vorrichtung zum ablesen von teststreifen
EP0653639B1 (en) * 1993-11-12 2000-03-22 Unilever Plc Analytical devices and methods of use thereof
US5647124A (en) * 1994-04-25 1997-07-15 Texas Instruments Incorporated Method of attachment of a semiconductor slotted lead to a substrate
GB9419267D0 (en) 1994-09-23 1994-11-09 Unilever Plc Assay devices
US5792294A (en) 1995-11-16 1998-08-11 Otis Elevator Company Method of replacing sheave liner
US5719600A (en) 1995-12-12 1998-02-17 Hewlett-Packard Company Gradient calculation system and method
US6113855A (en) * 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) * 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) * 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
GB9717926D0 (en) 1997-08-22 1997-10-29 Micromass Ltd Methods and apparatus for tandem mass spectrometry
AU2463299A (en) 1998-01-23 1999-08-09 Analytica Of Branford, Inc. Mass spectrometry from surfaces
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6831060B2 (en) * 1999-05-07 2004-12-14 Genentech, Inc. Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
CN1346680A (zh) * 2000-10-09 2002-05-01 北京大学 一种用于直接肌肉注射治疗糖尿病的人胰岛素前体基因和含有该基因的质粒
US6811785B2 (en) * 2001-05-07 2004-11-02 Mount Sinai School Of Medicine Of New York University Multivalent MHC class II—peptide chimeras
US6784154B2 (en) * 2001-11-01 2004-08-31 University Of Utah Research Foundation Method of use of erythropoietin to treat ischemic acute renal failure
EP1464069A2 (en) 2001-12-21 2004-10-06 Sense Proteomic Limited Probe for mass spectrometry
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
US6780645B2 (en) * 2002-08-21 2004-08-24 Lifescan, Inc. Diagnostic kit with a memory storing test strip calibration codes and related methods
US7045366B2 (en) 2003-09-12 2006-05-16 Ciphergen Biosystems, Inc. Photocrosslinked hydrogel blend surface coatings
US20040091961A1 (en) * 2002-11-08 2004-05-13 Evans Glen A. Enhanced variants of erythropoietin and methods of use
EP1616181B1 (en) 2003-04-17 2009-08-12 Vermillion, Inc. Polypeptides related to natriuretic peptides and methods of their identification and use
ZA200510282B (en) 2003-07-02 2007-03-28 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor
WO2005052593A1 (en) * 2003-10-29 2005-06-09 The University Of Leicester Detection
US7423139B2 (en) * 2004-01-20 2008-09-09 Insight Biopharmaceuticals Ltd. High level expression of recombinant human erythropoietin having a modified 5′-UTR
NZ552667A (en) * 2004-07-23 2009-04-30 Inst Medical W & E Hall Therapeutic and diagnostic agents
AU2005267720B2 (en) * 2004-08-05 2012-02-23 Genentech, Inc. Humanized anti-cmet antagonists
JP2006292623A (ja) * 2005-04-13 2006-10-26 Univ Of Dundee 心不全における突然死のマーカー
EP1731910A1 (en) 2005-06-07 2006-12-13 F. Hoffmann-La Roche Ag Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases
NZ576061A (en) * 2006-09-07 2013-02-22 Otago Innovation Ltd Biomarkers
GB0712670D0 (en) * 2007-06-29 2007-08-08 King S College London Isolated peptides and uses thereof
JP5818440B2 (ja) 2008-03-12 2015-11-18 オタゴ イノベーション リミテッド バイオマーカー
CA2715921A1 (en) * 2008-03-12 2009-09-17 Otago Innovation Limited Biomarkers

Similar Documents

Publication Publication Date Title
JP2011516038A5 (enExample)
US20190004065A1 (en) Biomarkers for stroke
CN102449486B (zh) 在患有呼吸困难的对象中检测细菌感染
CA2715921A1 (en) Biomarkers
JP2010513901A5 (enExample)
US20150010914A1 (en) Biomarkers for gastric cancer and uses thereof
JP2011514156A5 (enExample)
EP2828282B1 (en) Biomarkers
JP2011516037A5 (enExample)
JP2016507066A5 (enExample)
JP2014506244A5 (enExample)
JP2016511406A (ja) アルツハイマー病の診断のための方法と組成物
JP2017502253A5 (enExample)
US20230083393A1 (en) Multiple biomarkers for diagnosing lung cancer and use thereof
JP2018529931A5 (enExample)
RU2013158334A (ru) Средства и способы диагностики и лечения рассеянного склероза
JP5704684B2 (ja) IgG4関連疾患診断用マーカー及びその利用
JP2011529571A5 (enExample)
JP2012526543A5 (enExample)
JP2014224759A5 (enExample)
Rurali et al. Soluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patients
JP2013527427A5 (enExample)
US20140248637A1 (en) Composition for diagnosis of lung cancer and diagnosis kit of lung cancer
WO2006098464A1 (ja) 前立腺がんの診断方法
DK2391653T3 (en) Biomarkers associated nephropathy